Novo Nordisk stock heads into the open after a 7.65 percent drop
Published on 09/23/2026 at 04:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk stock closed at DKK 260.00 on Nasdaq Copenhagen on September 21, 2026, down 7.65 percent. The shares fell after the company presented its 2030 targets at its capital markets day, with Morningstar reporting that the shares fell 8 percent after the event.
September 21, 2026 in numbers
Novo Nordisk A/S (ISIN DK0060534915) closed at DKK 260.00 on Nasdaq Copenhagen on September 21, 2026, compared with a prior close of DKK 281.60. The 7.65 percent decline followed the company presentation, while the available session data place the intraday range at DKK 255.40 to DKK 260.70 and volume at 4.15 million shares.
Deutsche Bank cut its price target from DKK 265 to DKK 245 and kept a Sell rating after the capital markets day, according to Boerse.de. The stock remained within its reported 52-week range of DKK 224.30 to DKK 410.00.
Capital markets day remains relevant today
The capital markets day remains the central company-specific market item for September 23, 2026. Reuters reported on September 22, 2026, that Chief Executive Mike Doustdar said pills could capture as much as 50 percent of the global obesity-drug market by 2030.
The next quarterly results are scheduled for November 3, 2026, according to the company calendar data carried by Investing.com.
